Imagable 4T1 model for the study of late stage breast cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Tao, Kai ^a   Fang, Min ^a   Alroy, Joseph ^b   Gary, Gary G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANGIOGENIC FACTOR; CHEMOKINE; COLONY STIMULATING FACTOR; CYTOKINE; FIREFLY LUCIFERASE; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CANCER REGRESSION; CANCER STAGING; CELL DEATH; CELL GROWTH; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ENGINEERING; HEMATOPOIESIS; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LIVER CELL; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN MODIFICATION; SCID MOUSE; SIGNAL TRANSDUCTION; SPLEEN CELL; ANIMAL; BREAST TUMOR; DIAGNOSTIC IMAGING; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; HUMAN; METHODOLOGY; MOUSE MUTANT; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; NECROSIS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 51349151553     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-228     Document Type: Article

References (30)

1. Bibby MC Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages Eur J Cancer 2004, 40(6):852-857. 10.1016/ j.ejca.2003.11.021 15120041
2. Eccles SA Box G Court W Sandle J Dean CJ Preclinical models for the evaluation of targeted therapies of metastatic disease Cell Biophys 1994, 24-25:279-291. 7736534
3. Hoffman RM Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic Invest New Drugs 1999, 17(4):343-359. 10.1023/A:1006326203858 10759402
4. Vernon AE Bakewell SJ Chodosh LA Deciphering the molecular basis of breast cancer metastasis with mouse models Rev Endocr Metab Disord 2007, 8(3):199-213. 10.1007/s11154-007-9041-5 17657606
5. Miller FR Miller BE Heppner GH Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability Invasion Metastasis 1983, 3(1):22-31. 6677618
6. Miller FR Tumor subpopulation interactions in metastasis Invasion Metastasis 1983, 3(4):234-242. 6677628
7. Yoneda T Michigami T Yi B Williams PJ Niewolna M Hiraga T Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma Cancer 2000, 88(12 Suppl):2979-2988. 10.1002/1097-0142(20000615)88:12+ <2979::AID-CNCR13>3.0.CO;2-U 10898341
8. Lelekakis M Moseley JM Martin TJ Hards D Williams E Ho P Lowen D Javni J Miller FR Slavin J Anderson RL A novel orthotopic model of breast cancer metastasis to bone Clin Exp Metastasis 1999, 17(2):163-170. 10.1023/ A:1006689719505 10411109
9. Aslakson CJ Miller FR Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res 1992, 52(6):1399-1405. 1540948
10. Pulaski BA Ostrand-Rosenberg S Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines Cancer Res 1998, 58(7):1486-1493. 9537252
11. Eckhardt BL Parker BS van Laar RK Restall CM Natoli AL Tavaria MD Stanley KL Sloan EK Moseley JM Anderson RL Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix Mol Cancer Res 2005, 3(1):1-13. 15671244
12. Tao K Li J Warner J MacLeod K Miller FR Sahagian GG Multiple lysosomal trafficking phenotypes in metastatic mouse mammary tumor cell lines Int J Oncol 2001, 19(6):1333-1339. 11713608
13. Paddison PJ Caudy AA Bernstein E Hannon GJ Conklin DS Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells Genes Dev 2002, 16(8):948-958. 152352 11959843 10.1101/gad.981002
14. Kuhn K Baker SC Chudin E Lieu MH Oeser S Bennett H Rigault P Barker D McDaniel TK Chee MS A novel, high-performance random array platform for quantitative gene expression profiling Genome Res 2004, 14(11):2347-2356. 525694 15520296 10.1101/gr.2739104
15. Wright GW Simon RM A random variance model for detection of differential gene expression in small microarray experiments Bioinformatics 2003, 19(18):2448-2455. 10.1093/bioinformatics/btg345 14668230
16. Perez-Moreno M Fuchs E Catenins: Keeping cells from getting their signals crossed Dev Cell 2006, 11(5):601-612. 2405914 17084354 10.1016/ j.devcel.2006.10.010
17. DuPre SA Hunter KW Jr Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factors Exp Mol Pathol 2007, 82(1):12-24. 10.1016/j.yexmp.2006.06.007 16919266
18. Conti P DiGioacchino M MCP-1 and RANTES are mediators of acute and chronic inflammation Allergy Asthma Proc 2001, 22(3):133-137. 10.2500/ 108854101778148737 11424873
19. Azenshtein E Meshel T Shina S Barak N Keydar I Ben-Baruch A The angiogenic factors CXCL8 and VEGF in breast cancer: Regulation by an array of pro-malignancy factors Cancer Lett 2005, 217(1):73-86. 10.1016/ j.canlet.2004.05.024 15596298
20. Luu NT Rainger GE Nash GB Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils J Immunol 2000, 164(11):5961-5969. 10820279
21. Proost P Wuyts A Conings R Lenaerts JP Billiau A Opdenakker G Van Damme J Human and bovine granulocyte chemotactic protein-2: Complete amino acid sequence and functional characterization as chemokines Biochemistry 1993, 32(38):10170-10177. 10.1021/bi00089a037 8399143
22. Gallina G Dolcetti L Serafini P De Santo C Marigo I Colombo MP Basso G Brombacher F Borrello I Zanovello P Bicciato S Bronte V Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells J Clin Invest 2006, 116(10):2777-2790. 1578632 17016559 10.1172/ JCI28828
23. Bunt SK Sinha P Clements VK Leips J Ostrand-Rosenberg S Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression J Immunol 2006, 176(1):284-290. 16365420
24. DuPre SA Redelman D Hunter KW Jr The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci Int J Exp Pathol 2007, 88(5):351-360. 10.1111/ j.1365-2613.2007.00539.x 17877537
25. Connolly EM Harmey JH O'Grady T Foley D Roche-Nagle G Kay E Bouchier-Hayes DJ Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer Br J Cancer 2002, 87(2):231-237. 10.1038/sj.bjc.6600462 12107848
26. Denardo DG Johansson M Coussens LM Immune cells as mediators of solid tumor metastasis Cancer Metastasis Rev 2008, 27(1):11-18. 10.1007/ s10555-007-9100-0 18066650
27. DeNardo DG Coussens LM Inflammation and breast cancer. Balancing immune response: Crosstalk between adaptive and innate immune cells during breast cancer progression Breast Cancer Res 2007, 9(4):212. 2206719 17705880 10.1186/bcr1746
28. van Kempen LC de Visser KE Coussens LM Inflammation, proteases and cancer Eur J Cancer 2006, 42(6):728-734. 10.1016/j.ejca.2006.01.004 16524717
29. Adair-Kirk TL Senior RM Fragments of extracellular matrix as mediators of inflammation Int J Biochem Cell Biol 2007. 18243041
30. Li Y Kong L Yang Y Li K Mutant TNFalpha negatively regulates human breast cancer stem cells from MCF7 in vitro Cancer Biol Ther 2007, 6(9):1480-1489. 17881900